After hours:
Chart Events
Performance Outlook
| Previous Close | 132.25 |
| Open | 132.24 |
| Bid | 129.75 x 800 |
| Ask | 129.76 x 900 |
| Day's Range | 129.70 - 132.36 |
| 52 Week Range | 117.27 - 160.77 |
| Volume | |
| Avg. Volume | 7,913,301 |
| Market Cap | 359.772B |
| Beta (5Y Monthly) | 0.52 |
| PE Ratio (TTM) | 27.31 |
| EPS (TTM) | 4.75 |
| Earnings Date | Nov 15, 2022 |
| Forward Dividend & Yield | 2.24 (1.70%) |
| Ex-Dividend Date | Aug 11, 2022 |
| 1y Target Est | 141.88 |
- TheStreet.com
Costco Made a Huge Mistake Just Like Walmart and Target
The warehouse club admits that it made some errors, but it has a plan to fix the issue that should delight members.
- Reuters
Walmart, CVS must face lawsuit over placement of homeopathic products
The District of Columbia’s highest court revived two lawsuits that claim CVS and Walmart are misleading consumers by selling unproven homeopathic products alongside FDA-approved over-the-counter medicines on their store shelves and websites. The District of Columbia Court of Appeals on Thursday reversed lower-court rulings against the nonprofit Center for Inquiry (CFI), which alleged that CVS Pharmacy and Walmart are violating Washington, D.C.’s Consumer Protection Procedures Act by implying that homeopathic remedies and scientifically proven medicine are equally effective alternatives.
- Zacks
The Zacks Analyst Blog Highlights Berkshire Hathaway, Exxon Mobil, Walmart, Alibaba Group Holding and American Express
Berkshire Hathaway, Exxon Mobil, Walmart, Alibaba Group Holding and American Express are part of The Zacks top Analyst Blog.
